木瓜直播

Crystal Phend

Crystal Phend

Authors >

Crystal Phend

Crystal Phend is a contributing editor with 木瓜直播, where she's been covering medical news of all stripes since 2006.

Connect:

email image

Latest from Crystal Phend

Illustration of a stethoscope over the letters HFrEF over a heart in failure

Heart Failure With Reduced Ejection Fraction: Diagnosis and Evaluation

From history taking, the physical exam, and diagnostics to remote monitoring and wearables

Illustration of a hand holding a stethoscope over a heart in failure

For Your Patients: Getting the Most From Heart Failure Office Visits

A brief overview of what to expect and tips for how to prepare for and benefit from your medical appointments

TVT over a photo of the Phoenix Convention Center.

Real-World Data Affirms Next-Gen TAVR Device Advantage

TVT registry compares outcomes with Evolut FX and Pro+

TVT over a photo of the Phoenix Convention Center.

Strategies May Cut Pacing Needs With Navitor TAVR

Approval study analysis suggests best practices

TVT over a photo of the Phoenix Convention Center.

Poor Nutrition Status Linked With Survival After MitraClip

But procedure no less effective for this higher risk group, COAPT trial post hoc analysis shows

TVT over a photo of the Phoenix Convention Center.

Transapical Transcatheter Mitral Valve Replacement Trial Raises Questions

Pooled 2-year data show risks, raise concern about impact on ventricles

TVT over a photo of the Phoenix Convention Center.

MitraClip Shines in Real-World, Core-Lab Data

Benefits similar across anatomical complexity, advanced heart failure in post-marketing studies

TVT over a photo of the Phoenix Convention Center.

Novel LAA Closure Device 'Promising'

First-in-human experience weighs in on device that twists the left atrial appendage closed

A photo of a surgeon holding a donated heart.

Trial Affirms Safety of Circulatory-Death Heart Transplants

6-month results reported for perfusion-tested hearts outside of normal brain-death donation route

A photo of bottles of varying doses of Jakafi.

JAK Inhibitor Shows Promise in Severe Type of Sclerosis

Study finds genetic basis long sought in disabling pansclerotic morphea, leading to effective tx

鈥�

18

鈥�